Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Infants with RSV for Preventing Recurrent Wheeze (RSVD)
jRCTs031200376Completed
- Sponsor
- National Hospital Organization
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in respiratory syncytial virus disease (RSV) and recurrent wheeze comparing Vitamin D3 with Placebo (2 arms). Primary endpoint: Prevalence of wheezing for 12 months after entry. Started Jun 2021; status: completed.
02
Drugs
vitamin d
03
Conditions
respiratory syncytial virus disease (RSV)recurrent wheeze
Beyond the preview
Go deeper on jRCTs031200376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200376.